Natus Medical Stock Hits New 52-Week Low (BABY)

NEW YORK ( TheStreet) -- Natus Medical (Nasdaq: BABY) hit a new 52-week low Monday as it is currently trading at $9.03, below its previous 52-week low of $9.05 with 154,093 shares traded as of 2:30 p.m. ET. Average volume has been 347,600 shares over the past 30 days.

Natus Medical has a market cap of $286.7 million and is part of the health care sector and health services industry. Shares are down 32.9% year to date as of the close of trading on Friday.

Natus Medical Incorporated develops, manufactures, and markets neurodiagnostic and newborn care products worldwide. The company has a P/E ratio of 20, above the average health services industry P/E ratio of 19.2 and above the S&P 500 P/E ratio of 17.7.
  • Practice your BABY trading strategies and win cash in our stock game.

TheStreet Ratings rates Natus Medical as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and unimpressive growth in net income. You can view the full Natus Medical Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

null

More from Markets

Stocks Sink as Wall Street Grapples With Growth Concerns

Stocks Sink as Wall Street Grapples With Growth Concerns

How Movie Theaters and Real Estate Are Changing Going Into 2019

How Movie Theaters and Real Estate Are Changing Going Into 2019

As the Indices Approach New Lows, Focus on Flows Not Levels

As the Indices Approach New Lows, Focus on Flows Not Levels

What Is a Recession and What Causes It?

What Is a Recession and What Causes It?

Ameris Bancorp and Fidelity Southern Announce Merger Agreement

Ameris Bancorp and Fidelity Southern Announce Merger Agreement